The DOI matches its Crossref record; 244 of the 244 references it cites were found in a registry or an index.
Drug-induced cholestasis
Open accessAbstract
Recent progress in understanding the molecular mechanisms of bile formation and cholestasis have led to new insights into the pathogenesis of drug-induced cholestasis. This review summarizes their variable clinical presentations, examines the role of transport proteins in hepatic drug clearance and toxicity, and addresses the increasing importance of genetic determinants, as well as practical aspects of diagnosis and management. (HEPATOLOGY 2011;)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hoffmeyer, S., Burk, O., von Richter, O., Arnold, H. P., Brockmöller, J., Johne, A., Cascorbi, I., Gerloff, T., Roots, I., Eichelbaum, M., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.7.3473 · Cited by 2,365
Lee, W. M. (2003) · New England Journal of Medicine · doi:10.1056/nejmra021844 · Cited by 1,594
Jaeschke, H. (2002) · Toxicological Sciences · doi:10.1093/toxsci/65.2.166 · Cited by 1,304
Criteria of drug-induced liver disorders
(1990) · Journal of Hepatology · doi:10.1016/0168-8278(90)90124-a · Cited by 1,106
Mutations in the MDR 3 gene cause progressive familial intrahepatic cholestasis
de Vree, J. M. L., Jacquemin, E., Sturm, E., Cresteil, D., Bosma, P. J., Aten, J., Deleuze, J.-F., Desrochers, M., Burdelski, M., Bernard, O., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.1.282 · Cited by 735
Kullak-Ublick, G. A., Ismair, M. G., Stieger, B., Landmann, L., Huber, R., Pizzagalli, F., Fattinger, K., Meier, P. J., & Hagenbuch, B. (2001) · Gastroenterology · doi:10.1053/gast.2001.21176 · Cited by 723
Molecular Pathogenesis of Cholestasis
Trauner, M., Meier, P. J., & Boyer, J. L. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810223391707 · Cited by 706
Self-citationTirona, R. G., Leake, B. F., Merino, G., & Kim, R. B. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103792200 · Cited by 626
Molecular Pathogenesis of Cholestasis
Trauner, M., & Jansen, P. L. M. (2004) · Springer eBooks · doi:10.1007/978-1-4419-9034-1 · Cited by 610
Stieger, B., Fattinger, K., Madon, J., Kullak-Ublick, G. A., & Meier, P. J. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70224-1 · Cited by 582
Paulusma, C. C., Kool, M., Bosma, P. J., Scheffer, G. L., ter Borg, F., Scheper, R. J., Tytgat, G. N., Borst, P., Baas, F., & Elferink, R. O. (1997) · Hepatology · doi:10.1002/hep.510250635 · Cited by 552
Outcome and prognostic markers in severe drug‐induced liver disease†
Björnsson, E., & Olsson, R. (2005) · Hepatology · doi:10.1002/hep.20800 · Cited by 524
Jacquemin, E., Bernard, O., Hadchouel, M., Cresteil, D., De Vree, J. M. L., Paul, M., Elferink, R. P. J. O., Bosma, P. J., Sokal, E. M., Sturm, E., et al. (2001) · Gastroenterology · doi:10.1053/gast.2001.23984 · Cited by 523
Fattinger, K. (2001) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2001.114667 · Cited by 509
Hagenbuch, B., Stieger, B., Foguet, M., Lübbert, H., & Meier, P. J. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.23.10629 · Cited by 476
Kroetz, D. L., Pauli-Magnus, C., Hodges, L. M., Huang, C. C., Kawamoto, M., Johns, S. J., Stryke, D., Ferrin, T. E., DeYoung, J., Taylor, T., et al. (2003) · Pharmacogenetics · doi:10.1097/00008571-200308000-00006 · Cited by 429
Hepatic Injury Associated With Ketoconazole Therapy
Lewis, J. H., Zimmerman, H. J., Benson, G. D., & Ishak, K. G. (1984) · Gastroenterology · doi:10.1016/s0016-5085(84)80021-9 · Cited by 394
Mechanisms of bile formation, hepatic uptake, and biliary excretion.
Klaassen, C. D., & Watkins, J. B. (1984) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06642-6 · Cited by 390
Primary Sclerosing Cholangitis
(2007) · Gastroenterology Nursing · doi:10.1097/01.sga.0000267930.44372.16 · Cited by 382
Urquhart, B. L., Tirona, R. G., & Kim, R. B. (2007) · The Journal of Clinical Pharmacology · doi:10.1177/0091270007299930 · Cited by 373
Isoniazid-Associated Hepatitis in 114 Patients
Black, M., Mitchell, J. R., Zimmerman, H. J., Ishak, K. G., & Epler, G. R. (1975) · Gastroenterology · doi:10.1016/s0016-5085(19)32568-5 · Cited by 370
Endotoxin, reticuloendothelial function, and liver injury
Nolan, J. P. (1981) · Hepatology · doi:10.1002/hep.1840010516 · Cited by 367
Bergasa, N. V., Alling, D. W., Talbot, T. L., Swain, M. G., Yurdaydin, C., Turner, M. L., Schmitt, J. M., Walker, E. C., & Jones, E. A. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-123-3-199508010-00001 · Cited by 365
Th, M., van Nieuwkerk, C. M., Dingemans, K. P., Smit, J. J., Schinkel, A. H., Notenboom, R. G. E., Weerman, M. A. V. D. B., VERKRUISEN, R. P., Groen, A. K., & Elferink, R. P. J. O. (1994) · PubMed · Cited by 349
Daly, A. K., Aithal, G. P., Leathart, J. B. S., Swainsbury, R. A., Dang, T. S., & Day, C. P. (2007) · Gastroenterology · doi:10.1053/j.gastro.2006.11.023 · Cited by 348
Oral naltrexone treatment for cholestatic pruritus: A double-blind, placebo-controlled study
Wolfhagen, F., Sternieri, E., Hop, W., Vitale, G., Bertolotti, M., & Van Buuren, H. (1997) · Gastroenterology · doi:10.1053/gast.1997.v113.pm9322521 · Cited by 343
Lang, C., Meier, Y., Stieger, B., Beuers, U., Lang, T., Kerb, R., Kullak-Ublick, G. A., Meier, P. J., & Pauli-Magnus, C. (2007) · Pharmacogenetics and Genomics · doi:10.1097/01.fpc.0000230418.28091.76 · Cited by 339
MARSCHALL, H., WAGNER, M., ZOLLNER, G., FICKERT, P., DICZFALUSY, U., GUMHOLD, J., SILBERT, D., FUCHSBICHLER, A., BENTHIN, L., & GRUNDSTROM, R. (2005) · Gastroenterology · doi:10.1016/j.gastro.2005.05.009 · Cited by 325
TOXIC-ALLERGIC SYNDROME CAUSED BY INGESTION OF RAPESEED OIL DENATURED WITH ANILINE
Manuel Tabuenca, J. (1981) · The Lancet · doi:10.1016/s0140-6736(81)90949-1 · Cited by 319
Rockey, D. C., Seeff, L. B., Rochon, J., Freston, J., Chalasani, N., Bonacini, M., Fontana, R. J., & Hayashi, P. H. (2010) · Hepatology · doi:10.1002/hep.23577 · Cited by 313
Funk, C., Ponelle, C., Scheuermann, G., & Pantze, M. (2001) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12255-9 · Cited by 296
Hepatobiliary transporters and drug‐induced cholestasis†
Pauli‐Magnus, C., & Meier, P. J. (2006) · Hepatology · doi:10.1002/hep.21359 · Cited by 285
Hepatic Dysfunction During Hyperalimentation
Sheldon, G. F. (1978) · Archives of Surgery · doi:10.1001/archsurg.1978.01370160162028 · Cited by 285
HLA association of amoxicillin-clavulanate–induced hepatitis
Hautekeete, M. L., Horsmans, Y., van Waeyenberge, C., Demanet, C., Henrion, J., Verbist, L., Brenard, R., Sempoux, C., Michielsen, P. P., Yap, P. S. H., et al. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70404-x · Cited by 285
Herbal products for liver diseases: A therapeutic challenge for the new millennium
Schuppan, D., Jia, J.-D., Brinkhaus, B., & Hahn, E. G. (1999) · Hepatology · doi:10.1002/hep.510300437 · Cited by 279
Pauli-Magnus, C., Lang, T., Meier, Y., Zodan-Marin, T., Jung, D., Breymann, C., Zimmermann, R., Kenngott, S., Beuers, U., Reichel, C., et al. (2004) · Pharmacogenetics · doi:10.1097/00008571-200402000-00003 · Cited by 273
SECRETION OF ORGANIC ANIONS IN THE FORMATION OF URINE AND BILE
Sperber, I. (1959) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)07389-2 · Cited by 270
Drug–Induced Liver Injury: Mechanisms and Test Systems
Bissell, M. D., Gores, G. J., Laskin, D. L., & Hoofnagle, J. H. (2001) · Hepatology · doi:10.1053/jhep.2001.23505 · Cited by 267
Trauner, M., Arrese, M., Lee, H., Boyer, J. L., & Karpen, S. J. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1680 · Cited by 265
Self-citationCo-amoxiclav jaundice: clinical and histological features and HLA class II association
O'Donohue, J., Oien, K. A., Donaldson, P., Underhill, J., Clare, M., MacSween, R. N. M., & Mills, P. R. (2000) · Gut · doi:10.1136/gut.47.5.717 · Cited by 262
Traditional Remedies and Food Supplements: A 5-Year Toxicological Study (1991-1995)
Shaw, D., Leon, C., Kolev, S., & Murray, V. (1997) · Drug Safety · doi:10.2165/00002018-199717050-00006 · Cited by 260
BAGHERI, S. A., & BOYER, J. L. (1974) · Annals of Internal Medicine · doi:10.7326/0003-4819-81-5-610 · Cited by 256
Self-citationOral Medications With Significant Hepatic Metabolism at Higher Risk for Hepatic Adverse Events
Lammert, C., Bjornsson, E., Niklasson, A., & Chalasani, N. (2010) · Hepatology · doi:10.1002/hep.23317 · Cited by 251
Effect of sodium taurolithocholate on bile flow and bile acid excretion
Javitt, N. B., & Emerman, S. (1968) · Journal of Clinical Investigation · doi:10.1172/jci105790 · Cited by 248
Fluidity and Function of Hepatocyte Plasma Membranes
Schachter, D. (1984) · Hepatology · doi:10.1002/hep.1840040124 · Cited by 240
Meier, P. J., St Meier-Abt, A., Barrett, C., & Boyer, J. L. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)91006-9 · Cited by 227
Self-citationMeier, Y., Pauli-Magnus, C., Zanger, U. M., Klein, K., Schaeffeler, E., Nussler, A. K., Nussler, N., Eichelbaum, M., Meier, P. J., & Stieger, B. (2006) · Hepatology · doi:10.1002/hep.21214 · Cited by 219
Chitturi, S., & George, J. (2002) · Seminars in Liver Disease · doi:10.1055/s-2002-30102 · Cited by 216
Contribution of variant alleles of ABCB11 to susceptibility to intrahepatic cholestasis of pregnancy
Dixon, P. H., van Mil, S. W. C., Chambers, J., Strautnieks, S., Thompson, R. J., Lammert, F., Kubitz, R., Keitel, V, Glantz, A., Mattsson, L.-Å., et al. (2009) · Gut · doi:10.1136/gut.2008.159541 · Cited by 215
CYCLOSPORIN A HEPATOTOXICITY IN 66 RENAL ALLOGRAFT RECIPIENTS
KLINTMALM, G. B. G., IWATSUKI, S., & STARZL, T. E. (1981) · Transplantation · doi:10.1097/00007890-198112000-00007 · Cited by 205
Functional implications of liver cell heterogeneity
Gumucio, J. J., & Miller, D. L. (1981) · Gastroenterology · doi:10.1016/0016-5085(81)90732-0 · Cited by 204
Jones, A. E., & Bergasa, N. V. (1999) · Hepatology · doi:10.1002/hep.510290450 · Cited by 202
Some aspects of the interaction between natural and synthetic female sex hormones and the liver
Adlercreutz, H., & Tenhunen, R. (1970) · The American Journal of Medicine · doi:10.1016/s0002-9343(70)80130-9 · Cited by 198
Davis, R. A., Kern, F., Showalter, R., Sutherland, E., Sinensky, M., & Simon, F. R. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.9.4130 · Cited by 198
Acute Hepatitis Associated with the Chinese Herbal Product Jin Bu Huan
Woolf, G. M., Petrovic, L. M., Rojter, S. E., Wainwright, S., Villamil, F. G., Katkov, W. N., Michieletti, P., Wanless, I. R., Stermitz, F. R., Beck, J. J., et al. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-121-10-199411150-00001 · Cited by 196
Osteoporosis in Primary Biliary Cirrhosis: Effects of 25-Hydroxyvitamin D3 Treatment
Matloff, D. S., Kaplan, M. M., Neer, R. M., Goldberg, M. J., Bitman, W., & Wolfe, H. J. (1982) · Gastroenterology · doi:10.1016/s0016-5085(82)80291-6 · Cited by 195
New concepts of mechanisms of hepatocyte bile formation.
Boyer, J. L. (1980) · Physiological Reviews · doi:10.1152/physrev.1980.60.2.303 · Cited by 192
Self-citationHepatitis associated with amoxycillin-clavulanic acid combination report of 15 cases.
Larrey, D., Vial, T., Micaleff, A., Babany, G., Morichau-Beauchant, M., Michel, H., & Benhamou, J. P. (1992) · Gut · doi:10.1136/gut.33.3.368 · Cited by 190
Degott, C., Feldmann, G., Larrey, D., Durand-Schneider, A.-M., Grange, D., Machayekhi, J.-P., Moreau, A., Potet, F., & Benhamou, J.-P. (1992) · Hepatology · doi:10.1002/hep.1840150212 · Cited by 187
Risk of Acute Liver Injury Associated With the Combination of Amoxicillin and Clavulanic Acid
Rodríguez, L. A. G. (1996) · Archives of Internal Medicine · doi:10.1001/archinte.1996.00440110099013 · Cited by 181
Idiopathic adulthood ductopenia
Ludwig, J., Wiesner, R. H., & LaRusso, N. F. (1988) · Journal of Hepatology · doi:10.1016/s0168-8278(88)80482-3 · Cited by 179
Pathophysiology of cholestasis
Popper, H., & Schaffner, F. (1970) · Human Pathology · doi:10.1016/s0046-8177(70)80002-8 · Cited by 177
Funk, C. (2001) · Toxicology · doi:10.1016/s0300-483x(01)00460-7 · Cited by 177
Role of MRP2 and GSH in intrahepatic cycling of toxins
Dietrich, C. (2001) · Toxicology · doi:10.1016/s0300-483x(01)00459-0 · Cited by 177
Biliary sclerosis in patients receiving hepatic arterial infusions of floxuridine.
Hohn, D., Melnick, J., Stagg, R., Altman, D., Friedman, M., Ignoffo, R., Ferrell, L., & Lewis, B. (1985) · Journal of Clinical Oncology · doi:10.1200/jco.1985.3.1.98 · Cited by 176
Microfilament Dysfunction as a Possible Cause of Intrahepatic Cholestasis
Phillips, M. J., Oda, M., Mak, E., et al. (1975) · Gastroenterology · doi:10.1016/s0016-5085(19)32635-6 · Cited by 176
Hepatitis induced by Kava (Piper methysticum rhizoma)
Stickel, F., Baumüller, H.-M., Seitz, K., Vasilakis, D., Seitz, G., Seitz, H. K., & Schuppan, D. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00175-2 · Cited by 175
Lewis, J. H. (2000) · Medical Clinics of North America · doi:10.1016/s0025-7125(05)70287-x · Cited by 174
(1970) · Anesthesiology · doi:10.1097/00000542-197007000-00009 · Cited by 174
Acute hepatitis induced by greater celandine (Chelidonium majus)
Benninger, J., Schneider, H. T., Schuppan, D., Kirchner, T., & Hahn, E. G. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70410-5 · Cited by 173
Chronic Active Hepatitis and Severe Hepatic Necrosis Associated with Nitrofurantoin
SHARP, J. R., ISHAK, K. G., & ZIMMERMAN, H. J. (1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-92-1-14 · Cited by 171
Immune-mediated drug-induced liver disease
Liu, Z.-X., & Kaplowitz, N. (2002) · Clinics in Liver Disease · doi:10.1016/s1089-3261(02)00025-9 · Cited by 170
Hepatotoxicity to sodium valproate: a review.
Powell-Jackson, P. R., Tredger, J. M., & Williams, R. (1984) · Gut · doi:10.1136/gut.25.6.673 · Cited by 170
Suzuki, A., Andrade, R. J., Bjornsson, E., Lucena, M. I., Lee, W. M., Yuen, N. A., Hunt, C. M., & Freston, J. W. (2010) · Drug Safety · doi:10.2165/11535340-000000000-00000 · Cited by 169
Wheeler, H. O., & Ramos, O. L. (1960) · Journal of Clinical Investigation · doi:10.1172/jci104015 · Cited by 169
Mixed Hepatocellular–Cholestatic Liver Injury after Pioglitazone Therapy
May, L. D., Lefkowitch, J. H., Kram, M. T., & Rubin, D. E. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-136-6-200203190-00008 · Cited by 167
Meier, Y., Zodan, T., Lang, C., Zimmermann, R., Kullak-Ublick, G. A., Meier, P. J., Stieger, B., & Pauli-Magnus, C. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.38 · Cited by 165
Fatal cholestatic jaundice in elderly patients taking benoxaprofen.
Taggart, H. M., & Alderdice, J. M. (1982) · BMJ · doi:10.1136/bmj.284.6326.1372 · Cited by 165
Böhme, M., Müller, M., Leier, I., Jedlitschky, G., & Keppler, D. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90084-1 · Cited by 164
The danger hypothesis—potential role in idiosyncratic drug reactions
Pirmohamed, M., Naisbitt, D. J., Gordon, F., & Park, B. K. (2002) · Toxicology · doi:10.1016/s0300-483x(02)00255-x · Cited by 164
Lu, H., Choudhuri, S., Ogura, K., Csanaky, I. L., Lei, X., Cheng, X., Song, P.-Z., & Klaassen, C. D. (2008) · Toxicological Sciences · doi:10.1093/toxsci/kfn038 · Cited by 163
Serious liver disease induced by infliximab
Tobon, G. J., Cañas, C., Jaller, J.-J., Restrepo, J.-C., & Anaya, J.-M. (2007) · Clinical Rheumatology · doi:10.1007/s10067-005-0169-y · Cited by 160
Sclerosing Cholangitis after Continuous Hepatic Artery Infusiori of FUDR
KEMENY, M. M., BATTIFORA, H., BLAYNEY, D. W., CECCHI, G., GOLDBERG, D. A., LEONG, L. A., MARGOLIN, K. A., & TERZ, J. J. (1985) · Annals of Surgery · doi:10.1097/00000658-198508000-00007 · Cited by 159
The causes of obvious jaundice in South West Wales: perceptions versus reality
Whitehead, M. W. (2001) · Gut · doi:10.1136/gut.48.3.409 · Cited by 155
Floxuridine-induced sclerosing cholangitis: An ischemic cholangiopathy?
Ludwig, J., Kim, C. H., Wiesner, R. H., & Krom, R. A. F. (1989) · Hepatology · doi:10.1002/hep.1840090209 · Cited by 155
Mita, S., Suzuki, H., Akita, H., Hayashi, H., Onuki, R., Hofmann, A. F., & Sugiyama, Y. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.008748 · Cited by 155
Cytochemical localization of Na+, K+-ATPase in the rat hepatocyte.
Blitzer, B. L., & Boyer, J. L. (1978) · Journal of Clinical Investigation · doi:10.1172/jci109216 · Cited by 153
Self-citationFriis, H., & Andreasen, P. B. (1992) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1992.tb00562.x · Cited by 150
Velayudham, L. S., & Farrell, G. C. (2003) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2.3.287 · Cited by 148
Bile ductular cholestasis: An ominous histopathologic sign related to sepsis and “cholangitis lenta”
Lefkowitch, J. H. (1982) · Human Pathology · doi:10.1016/s0046-8177(82)80134-2 · Cited by 147
Does Long‐Term Home Parenteral Nutrition in Adult Patients Cause Chronic Liver Disease?
Bowyer, B. A., Fleming, C. R., Ludwig, J., Petz, J., & McGill, D. B. (1985) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/014860718500900111 · Cited by 146
Role of the bile salt export pump, BSEP, in acquired forms of cholestasis
Stieger, B. (2009) · Drug Metabolism Reviews · doi:10.3109/03602530903492004 · Cited by 141
The Enigma of Intrahepatic Cholestasis of Pregnancy: Lessons from Chile
Reyes, H. (1982) · Hepatology · doi:10.1002/hep.1840020114 · Cited by 140
Chaparral ingestion. The broadening spectrum of liver injury caused by herbal medications
Gordon, D. (1995) · JAMA · doi:10.1001/jama.273.6.489 · Cited by 137
Reau, N. S., & Jensen, D. M. (2008) · Clinics in Liver Disease · doi:10.1016/j.cld.2007.11.007 · Cited by 133
Böhme, M., Büchler, M. W., Müller, M. M., & KEPPLER, D. O. R. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)80403-h · Cited by 127
Ticrynafen-Associated Hepatic Injury: Analysis of 340 Cases
Zimmerman, H. J., Lewis, J. H., Ishak, K. G., & Maddrey, W. C. (1984) · Hepatology · doi:10.1002/hep.1840040223 · Cited by 126
Dujovne, C. A., Chan, C. H., & Zimmerman, H. J. (1967) · New England Journal of Medicine · doi:10.1056/nejm196710122771503 · Cited by 126
Chlorpromazine-induced vanishing bile duct syndrome leading to biliary cirrhosis
Moradpour, D., Altorfer, J., Flury, R., Greminger, P., Meyenberger, C. M., Jost, R., & Schmid, M. (1994) · Hepatology · doi:10.1002/hep.1840200610 · Cited by 123
An Industrial Outbreak of Toxic Hepatitis Due to Methylenedianiline
McGill, D. B., & Motto, J. D. (1974) · New England Journal of Medicine · doi:10.1056/nejm197408082910604 · Cited by 122
Estrogen-Induced Cholestasis: Clues to Pathogenesis and Treatment
Schreiber, A. J., & Simon, F. R. (1983) · Hepatology · doi:10.1002/hep.1840030422 · Cited by 122
[Toxic and drug-induced hepatitis].
de Albornoz, M. M. C., Echebarría, R. U., Alvarez, J. S., Herranz, M. A. S., Bragado, F. G., & Puente, A. R. (1988) · PubMed · Cited by 122
Hepatic Injury Associated with Diphenylhydantoin Therapy. A Clinicopathologic Study of 20 Cases
Mullick, F. G., & Ishak, K. G. (1980) · American Journal of Clinical Pathology · doi:10.1093/ajcp/74.4.442 · Cited by 121
Phenobarbital Effects in Cholestatic Liver Disease
BLOOMER, J. R., & BOYER, J. L. (1975) · Annals of Internal Medicine · doi:10.7326/0003-4819-82-3-310 · Cited by 120
Self-citationScheuer, P. J., Lal, S., Summerfield, J. A., & Sherlock, S. (1974) · The Lancet · doi:10.1016/s0140-6736(74)92381-2 · Cited by 120
Drug- and chemical-induced cholestasis
Mohi-Ud-Din, R., & Lewis, J. H. (2004) · Clinics in Liver Disease · doi:10.1016/s1089-3261(03)00124-7 · Cited by 119
Causes and characteristics of 500 consecutive cases of jaundice.
Malchow-møller, A., Matzen, P., Bjerregaard, B. E., Hilden, J., Holst-Christensen, J., Staehr-Johansen, T., Altman, L., Thomsen, C., & Juhl, E. (1981) · PubMed · Cited by 118
Mechanisms of Hepatic Transport of Drugs: Implications for Cholestatic Drug Reactions
Bohan, A., & Boyer, J. L. (2002) · Seminars in Liver Disease · doi:10.1055/s-2002-30099 · Cited by 117
Self-citationMARCHAND, Y. L., Patzelt, C., Assimacopoulos‐Jeannet, F., et al. (1974) · Journal of Clinical Investigation · doi:10.1172/jci107701 · Cited by 115
Phillips, M. J., Poucell, S., & Oda, M. (1986) · PubMed · Cited by 115
Bergasa, N. V. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.09.004 · Cited by 113
Efficacy of troleandomycin in outpatients with severe, corticosteroid-dependent asthma
Zeiger, R. S., Schatz, M. X., Sperling, W. L., et al. (1980) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(80)90003-2 · Cited by 108
Antineoplastic agents and the liver
Ménard, D. B., Gisselbrecht, C., Marty, M. E., Reyes, F., & Dhumeaux, D. (1980) · Gastroenterology · doi:10.1016/0016-5085(80)90205-x · Cited by 108
Section 4 Adverse reactions to non-steroidal antirheumatic drugs
Cuthbert, M. F. (1974) · Current Medical Research and Opinion · doi:10.1185/03007997409115265 · Cited by 107
Erlinger, S. (1997) · Journal of Hepatology · doi:10.1016/s0168-8278(97)82326-4 · Cited by 107
Androgenic/Anabolic Steroid-Induced Toxic Hepatitis
Štimac, D., Milić, S., Dobrila-Dintinjana, R., Kovač, D., & Ristič, S. (2002) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-200210000-00013 · Cited by 107
Kadmon, M., Klünemann, C., Böhme, M., Ishikawa, T., Gorgas, K., Otto, G., Herfarth, C. H., & KEPPLER, D. O. R. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)90363-h · Cited by 106
Nimesulide-induced acute hepatitis: evidence from six cases
Steenbergen, W. V., Peeters, P., Bondt, J. D., Staessen, D., Buscher, H., Laporta, T., Roskams, T., & Desmet, V. J. (1998) · Journal of Hepatology · doi:10.1016/s0168-8278(98)80188-8 · Cited by 101
Hautekèete, M., Brenard, R., Horsmans, Y., Henrion, J., Verbist, L., Derue, G., Druez, P., Omar, M., Kockx, M. M., Hubens, H., et al. (1995) · Journal of Hepatology · doi:10.1016/0168-8278(95)80262-2 · Cited by 100
Lang, T., Haberl, M., Jung, D., Drescher, A., Schlagenhaufer, R., Keil, A., Mornhinweg, E., Stieger, B., Kullak-Ublick, G. A., & Kerb, R. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.008854 · Cited by 99
Female Sex Steroids and Cholestasis
Kreek, M. J. (1987) · Seminars in Liver Disease · doi:10.1055/s-2008-1040559 · Cited by 98
Regulation of human hepatic drug transporter expression by pro-inflammatory cytokines
Fardel, O., & Vée, M. L. (2009) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425250903304056 · Cited by 97
Stramentinoli, G., Padova, C. D., Gualano, M. R., Rovagnati, P., & Galli-Kienle, M. (1981) · Gastroenterology · doi:10.1016/0016-5085(81)90206-7 · Cited by 97
Barnwell, S. G., Lowe, P. J., & COLEMAN, R. (1984) · Biochemical Journal · doi:10.1042/bj2200723 · Cited by 97
Morimoto, K., Oishi, T., Ueda, S., Ueda, M., Hosokawa, M., & Chiba, K. (2004) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.19.453 · Cited by 96
Hepatotoxicity of Erythromycin
Braun, P. (1969) · The Journal of Infectious Diseases · doi:10.1093/infdis/119.3.300 · Cited by 95
Hepatic injury associated with itraconazole
Lavrijsen, A. P. M., Balmus, K. J., Nugteren‐Huying, W. M., Roldaan, A. C., Wout, J. W. V., & Stricker, B. H. C. (1992) · The Lancet · doi:10.1016/0140-6736(92)90527-a · Cited by 95
Davies, M. H., Harrison, R. F., Elias, E., & Hübscher, S. G. (1994) · Journal of Hepatology · doi:10.1016/s0168-8278(05)80476-3 · Cited by 95
Hepatobiliary complications of oral contraceptives
LINDBERG, M. C. (1992) · Journal of General Internal Medicine · doi:10.1007/bf02598014 · Cited by 94
Chronic chlorpromazine jaundice
Read, A. E., Harrison, C., & Sherlock, S. (1961) · The American Journal of Medicine · doi:10.1016/0002-9343(61)90113-9 · Cited by 89
AZATHIOPRINE AND PREDNISONE IN THE TREATMENT OF ADULTS WITH LUPUS NEPHRITIS
Drinkard, J. P., Stanley, T. M., Dornfeld, L., Austin, R. C., Barnett, E. V., Pearson, C. M., Vernier, R. L., Adams, D. A., Latta, H., & Gonick, H. C. (1970) · Medicine · doi:10.1097/00005792-197009000-00004 · Cited by 89
Amoxicillin-clavulanate potassium-associated cholestasis
Reddy, K. R., Brillant, P. T., & Schiff, E. R. (1989) · Gastroenterology · doi:10.1016/0016-5085(89)91633-8 · Cited by 87
Acute Hepatitis Induced by Greater Celandine ( Chelidonium majus )
Stickel, F., Pöschl, G., Seitz, H. K., Waldherr, R., Hahn, E. G., & Schuppan, D. (2003) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520310000942 · Cited by 87
Zimmerman, H. J., & Lewis, J. H. (1987) · Medical Toxicology · doi:10.1007/bf03260010 · Cited by 87
THE LIVER LESION OF THE EPPING JAUNDICE
Kopelman, H. A., Scheuer, P. J., & Williams, R. L. (1966) · QJM · doi:10.1093/oxfordjournals.qjmed.a067093 · Cited by 87
Boyer, J. L. (1983) · Hepatology · doi:10.1002/hep.1840030423 · Cited by 86
Self-citationNovak, D. J., & Lewis, J. H. (2003) · Current Opinion in Internal Medicine · doi:10.1097/00132980-200302030-00001 · Cited by 85
Nadir, A., Reddy, D., & Thiel, D. H. V. (2000) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(00)02179-1 · Cited by 85
Bolder, U., Trang, N. V., Hagey, L. R., Schteingart, C. D., Ton‐Nu, H., Cerré, C., Elferink, R. P. J. O., & Hofmann, A. F. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70356-2 · Cited by 82
Intrahepatic cholestasis as a canalicular motility disorder. Evidence using cytochalasin.
Mj, P., Oshio, C., Miyairi, M., & Smith, C. S. (1983) · PubMed · Cited by 80
Gallagher, T. F., Mueller, M. N., & Kappas, A. (1966) · Medicine · doi:10.1097/00005792-196645060-00010 · Cited by 79
Acute Liver Disease Associated with Erythromycins, Sulfonamides, and Tetracyclines
Carson, J. L., Strom, B. L., Duff, A., Gupta, A., Shaw, M., Lundin, F. E., & Das, K. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-7_part_1-199310010-00005 · Cited by 78
Drug-associated acute-onset vanishing bile duct and Stevens–Johnson syndromes in a child
Srivastava, M. D., Pérez‐Atayde, A. R., & Jonas, M. M. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70154-4 · Cited by 77
Phenylbutazone liver injury: A clinical-pathologic survey of 23 cases and review of the literature
Benjamin, S. B., Ishak, K. G., Zimmerman, H. J., & Grushka, A. (1981) · Hepatology · doi:10.1002/hep.1840010311 · Cited by 77
Schaffner, F., Pópper, H., & PÉREZ, V. U. (1960) · PubMed · Cited by 77
Lakehal, F., Dansette, P. M., Becquemont, L., Lasnier, E., Delelo, R., Balladur, P., Poupon, R. Y., Beaune, P. H., & Housset, C. (2001) · Chemical Research in Toxicology · doi:10.1021/tx0002435 · Cited by 76
Bramow, S., Ott, P., Nielsen, F. T., Bangert, K., Tygstrup, N., & Dalhoff, K. (2001) · Pharmacology & Toxicology · doi:10.1034/j.1600-0773.2001.d01-147.x · Cited by 75
Liver injury from cyclosporine A
Kassianides, C., Nussenblatt, R. B., Palestine, A. G., Mellow, S. D., & Hoofnagle, J. H. (1990) · Digestive Diseases and Sciences · doi:10.1007/bf01540169 · Cited by 73
Carbamazepine hepatotoxicity: Another cause of the vanishing bile duct syndrome
Forbes, G. M., Jeffrey, G. P., SHILKIN, K. B., & REED, W. D. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)90780-3 · Cited by 72
Bile duct epithelium: frontiers in transport physiology
Boyer, J. L. (1996) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1996.270.1.g1 · Cited by 71
Self-citationPruritus in cholestasis: No direct causative role for bile acid retention
Freedman, M. R., Holzbach, R., & Ferguson, D. R. (1981) · The American Journal of Medicine · doi:10.1016/0002-9343(81)90857-3 · Cited by 71
Idiopathic Biliary Ductopenia in Adults without Symptoms of Liver Disease
Moreno, A., Carréño, V., Cano, A., & González, C. (1997) · New England Journal of Medicine · doi:10.1056/nejm199703203361204 · Cited by 71
Chaparral-induced hepatic injury.
Batchelor, W., Heathcote, J., & Wanless, I. R. (1995) · PubMed · Cited by 69
Hepatotoxicity of Antimicrobial Agents
Brown, S., & Desmond, P. (2002) · Seminars in Liver Disease · doi:10.1055/s-2002-30103 · Cited by 69
Tetracycline-induced bile duct paucity and prolonged cholestasis
Hunt, C. M., & Washington, K. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90830-3 · Cited by 68
Drug and toxin-induced bile duct disorders
Geubel, A. P., & Sempoux, C. L. (2000) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.2000.2369.x · Cited by 68
Histopathologic changes associated with fialuridine hepatotoxicity.
Kleiner, D. E., Gaffey, M. J., Sallie, R., Tsokos, M., Nichols, L., McKenzie, R., Straus, S. E., & Hoofnagle, J. H. (1997) · PubMed · Cited by 68
Bonkovsky, H. L., Azar, R. R., Bird, S. B., Szabó, G., & Banner, B. F. (2002) · Digestive Diseases and Sciences · doi:10.1023/a:1015895925374 · Cited by 67
Captopril-Associated Cholestatic Jaundice
Rahmat, J., GELFAND, R. L., GELFAND, M. C., WINCHESTER, J. F., SCHREINER, G. E., & Zimmerman, H. J. (1985) · Annals of Internal Medicine · doi:10.7326/0003-4819-102-1-56 · Cited by 67
DePinho, R. A., Goldberg, C. S., & Lefkowitch, J. H. (1984) · PubMed · Cited by 66
A Role for the Pregnane X Receptor in Flucloxacillin-Induced Liver Injury
Andrews, E., Armstrong, M., Tugwood, J. D., Swan, D., Glaves, P. D., Pirmohamed, M., Aithal, G. P., Wright, M. C., Day, C. P., & Daly, A. K. (2010) · Hepatology · doi:10.1002/hep.23549 · Cited by 66
Haloperidol-Induced Chronic Cholestatic Liver Disease
Dincsoy, H. P., & Saelinger, D. A. (1982) · Gastroenterology · doi:10.1016/s0016-5085(82)80209-6 · Cited by 65
Hepatic injury associated with paraquat toxicity in humans
Mullick, F. G., Ishak, K. G., Mahabir, R., & Stromeyer, F. W. (1981) · Liver International · doi:10.1111/j.1600-0676.1981.tb00035.x · Cited by 65
Bataille, L., Rahier, J., & Geubel, A. P. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00268-4 · Cited by 65
Al-Kawas, F. H., SEEFF, L. B., BERENDSON, R. A., Zimmerman, H. J., & ISHAK, K. G. (1981) · Annals of Internal Medicine · doi:10.7326/0003-4819-95-5-588 · Cited by 64
Effect of estrogens on the liver
Kern, F., Erfling, W., Simon, F. R., et al. (1978) · Gastroenterology · doi:10.1016/0016-5085(78)90860-0 · Cited by 63
Biliary Cirrhosis Induced by Chlorpromazine
Walker, C. O., & Combes, B. (1966) · Gastroenterology · doi:10.1016/s0016-5085(19)34313-6 · Cited by 63
Terminal hepatic failure following a small dose of sulfamethoxazole-trimethoprim
Ransohoff, D. F., & Jacobs, G. H. (1981) · Gastroenterology · doi:10.1016/0016-5085(81)90146-3 · Cited by 62
Progressive bile duct injury after thiabendazole administration
Manivel, J. C., Bloomer, J. R., & Snover, D. C. (1987) · Gastroenterology · doi:10.1016/0016-5085(87)91009-2 · Cited by 61
Prolonged cholestasis due to trimethoprim sulfamethoxazole
Kowdley, K. V., Keeffe, E. B., & Fawaz, K. A. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)90346-z · Cited by 60
Risperidone-induced cholestatic hepatitis
Krebs, S., Dormann, H., Muth‐Selbach, U., Hahn, E. G., Brune, K., & Schneider, H. T. (2001) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200101000-00013 · Cited by 59
Reversible symptomatic biliary obstruction associated with ceftriaxone pseudolithiasis.
Zinberg, J., Chernaik, R., Coman, E., Rosenblatt, R., & Brandt, L. J. (1991) · PubMed · Cited by 58
CASE REPORT: Azithromycin-Induced Intrahepatic Cholestasis
Chandrupatla, S., Demetris, A. J., & Rabinovitz, M. (2002) · Digestive Diseases and Sciences · doi:10.1023/a:1020170807742 · Cited by 58
MECHANISMS OF DRUG-INDUCED LIVER DISEASE
DeLeve, L. D., & Kaplowitz, N. (1995) · Gastroenterology Clinics of North America · doi:10.1016/s0889-8553(21)00228-4 · Cited by 58
Severe Jaundice in Sweden in the New Millennium: Causes, Investigations, Treatment and Prognosis
Björnsson, E., Ismael, S., Nejdet, S., & Kilander, A. F. (2003) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520310000492 · Cited by 57
Fulminant liver failure and pancreatitis associated with the use of sulfamethoxazole-trimethoprim.
Alberti‐Flor, J. J., Hernandez, M. E., Jp, F., Howell, S., & Jeffers, L. J. (1989) · PubMed · Cited by 56
Acute vanishing bile duct syndrome after ibuprofen therapy in a child
Taghian, M., Tran, T.-A., Bresson‐Hadni, S., Menget, A., Felix, S. A., & Jacquemin, E. (2004) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2004.05.027 · Cited by 56
Levy, C., & Lindor, K. D. (2003) · Clinics in Liver Disease · doi:10.1016/s1089-3261(03)00032-1 · Cited by 56
Cyclosporin A reduces canalicular membrane fluidity and regulates transporter function in rats
Yasumiba, S., Tazuma, S., Ochi, H., Chayama, K., & Kajiyama, G. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3540591 · Cited by 54
Hepatotoxicity of antibiotics.
Hautekeete, M. L. (1995) · PubMed · Cited by 53
Total parenteral nutrition solution increases bile lithogenicity in rat
Gimmon, Z., Kelley, R. E., Simko, V., & Fischer, J. E. (1982) · Journal of Surgical Research · doi:10.1016/0022-4804(82)90100-7 · Cited by 53
Jaundice associated with naproxen
Victorino, R. M. M., da Silveira, J. C. B., Baptista, A., & de Moura, M. C. (1980) · Postgraduate Medical Journal · doi:10.1136/pgmj.56.655.368 · Cited by 53
Prolonged cholestasis and progressive hepatic fibrosis following imipramine therapy
Horst, D. A., Grace, N. D., & LeCompte, P. M. (1980) · Gastroenterology · doi:10.1016/0016-5085(80)90383-2 · Cited by 52
Molecular identification and functional characterization of Mdr1a in rat cholangiocytes
Gigliozzi, A., Fraioli, F., Sundaram, P., Lee, J., Mennone, A., Alvaro, D., & Boyer, J. L. (2000) · Gastroenterology · doi:10.1053/gast.2000.18156 · Cited by 52
Self-citationProgressive Cholestatic Liver Disease Associated with Clarithromycin Treatment
Fox, J. C., Szyjkowski, R. D., Sanderson, S. O., & Levine, R. A. (2002) · The Journal of Clinical Pharmacology · doi:10.1177/00970002042006011 · Cited by 51
Román, I. D. (2003) · Toxicological Sciences · doi:10.1093/toxsci/71.2.276 · Cited by 51
Human drug hepatotoxicity: a contemporary clinical perspective
Assis, D. N., & Navarro, V. J. (2009) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425250902927386 · Cited by 50
Smith, L., Ignacio, J., Winesett, M. P., Kaiser, G., Lacson, A. G., Gilbert‐Barness, E., González‐Peralta, R. P., & Wilsey, M. J. (2005) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/01.mpg.0000178086.44155.73 · Cited by 49
Bengoa, J. M., Hanauer, S. B., Sitrin, M. D., et al. (1985) · Hepatology · doi:10.1002/hep.1840050117 · Cited by 48
Kostrubsky, V. E., Vore, M. E., Kindt, E. K., Burliegh, J., Rogers, K. L., Peter, G., Altrogge, D. M., & Sinz, M. (2001) · PubMed · Cited by 48
Okan, G., Yaylacı, S., Peker, Ö., Kaymakoğlu, S., & Saruç, M. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.4697 · Cited by 47
Drug-induced vanishing bile duct syndrome: response to ursodiol.
O'Brien, C., Shields, D. S., Saul, S. H., & Reddy, K. R. (1996) · PubMed · Cited by 45
Greaves, M. W., & Dawber, R. P. R. (1970) · BMJ · doi:10.1136/bmj.2.5703.237-b · Cited by 45
Trimethoprim-Sulfamethoxazole-Induced Intrahepatic Cholestasis
NAIR, S. S., KAPLAN, J. M., LEVINE, L. H., & GERACI, K. (1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-92-4-511_2 · Cited by 44
Increased tight junction permeability: a possible mechanism of oestrogen cholestasis
Elias, E., Iqbal, S., Knutton, S., et al. (1983) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1983.tb00118.x · Cited by 44
Cholestatic hepatitis related to quinolones: a report of two cases
Hautekèete, M., Kockx, M. M., Naegels, S., Holvoet, J., Hubens, H., & Klöppel, G. (1995) · Journal of Hepatology · doi:10.1016/0168-8278(95)80045-x · Cited by 44
Levy, C., & Lindor, K. D. (2003) · Clinics in Liver Disease · doi:10.1016/s1089-3261(03)00097-7 · Cited by 43
Cholestatic liver injury after glimepiride therapy
Chounta, A., Zouridakis, S., Ellinas, C., Tsiodras, S., Zoumpouli, C., Kopanakis, S., & Giamarellou, H. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.02.011 · Cited by 43
Intrahepatic Cholestasis after Griseofulvin Administration
Chiprut, R. O., Viteri, A. L., Jamroz, C., & Dyck, W. P. (1976) · Gastroenterology · doi:10.1016/s0016-5085(76)80327-7 · Cited by 43
Possible Ranitidine Hepatotoxicity
Black, M., SCOTT, W. E., & KANTER, R. (1984) · Annals of Internal Medicine · doi:10.7326/0003-4819-101-2-208 · Cited by 42
Cited by
Meier, P. J., & Stieger, B. (2002) · Annual Review of Physiology · doi:10.1146/annurev.physiol.64.082201.100300 · Cited by 586
The adverse outcome pathway concept: A pragmatic tool in toxicology
Vinken, M. (2013) · Toxicology · doi:10.1016/j.tox.2013.08.011 · Cited by 467
CSH guidelines for the diagnosis and treatment of drug-induced liver injury
Drug-induced Liver Injury (DILI) Study Group, Yu, Y.-C., Chinese Society of Hepatology (CSH), Chinese Medical Association (CMA), Mao, Y.-M., Chen, C.-W., Chen, J.-J., Chen, J., Cong, W.-M., Ding, Y., et al. (2017) · Hepatology International · doi:10.1007/s12072-017-9793-2 · Cited by 254
Hepatic 3D spheroid models for the detection and study of compounds with cholestatic liability
Hendriks, D. F. G., Fredriksson Puigvert, L., Messner, S., Mortiz, W., & Ingelman-Sundberg, M. (2016) · Scientific Reports · doi:10.1038/srep35434 · Cited by 156
Sundaram, V., & Björnsson, E. S. (2017) · Hepatology Communications · doi:10.1002/hep4.1088 · Cited by 138
Metadata
- Authors
- Padda, M. S., Sanchez, M., Akhtar, A. J., & Boyer, J. L.
- Venue
- Hepatology
- Published
- 2011-04
- Volume
- 53
- Issue
- 4
- Pages
- 1377-1387
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2102136872
- Cited by
- 387
- References
- 244
- FWCI
- 20.41
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.